Outcome and histopathologic regression in oral squamous cell carcinoma after preoperative radiochemotherapy

Strahlentherapie und Onkologie

Volumn 185, Issue 5, 2009, Pages 296-302

  Driemel, Oliver ^a   Ettl, Tobias ^a   Kölbl, Oliver ^a   Reichert, Torsten E ^a   Dresp, Bernd V ^b   Reuther, Jürgen ^b   Pistner, Hans ^c  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^b UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^c HELIOS KLINIKUM ERFURT   (Germany)

Author keywords

Cis carboplatin; Histological regression; Oral squamous cell carcinoma; Preoperative radiochemotherapy; Survival

Indexed keywords

CARBOPLATIN; CISPLATIN;

ADD ON THERAPY; ADULT; AGED; ARTICLE; BIOPSY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; DISEASE FREE SURVIVAL; DISTANT METASTASIS; FEMALE; FOLLOW UP; HUMAN; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; MOUTH CARCINOMA; MULTIMODALITY CANCER THERAPY; NECK DISSECTION; PREOPERATIVE TREATMENT; RADIATION DOSE; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; SURVIVAL TIME; THERAPY DELAY; TREATMENT OUTCOME; TUMOR CLASSIFICATION; TUMOR REGRESSION;

ADULT; AGED; ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; INCIDENCE; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MOUTH NEOPLASMS; PREOPERATIVE CARE; RADIOTHERAPY, CONFORMAL; RISK ASSESSMENT; RISK FACTORS; SURVIVAL ANALYSIS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 65649106519     PISSN: 01797158     EISSN: 1439099X     Source Type: Journal    
DOI: 10.1007/s00066-009-1914-y     Document Type: Article

References (43)

1. D.J. Adelstein Y. Li G.L. Adams 2003 An Intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer J Clin Oncol 21 92 8
2. J. Bernier C. Domenge M. Ozsahin 2004 Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer N Engl J Med 350 1945 52 (Pubitemid 38580197)
3. E. Bolke P.A. Gerber G. Lammering 2008 Development and management of severe cutaneous side effects in head-and-neck cancer patients during concurrent radiotherapy and cetuximab Strahlenther Onkol 184 105 10
4. D. Bottke K. Bathe T. Wiegel 2007 Phase I trial of radiochemotherapy with bendamustine in patients with recurrent squamous cell carcinoma of the head and neck Strahlenther Onkol 183 128 32 (Pubitemid 46364895)
5. O.M. Braun B. Neumeister W. Popp 1989 Histologic tumor regression grades in squamous cell carcinoma of the head and neck after preoperative radiochemotherapy Cancer 63 1097 100 (Pubitemid 19074738)
6. P.B. Chougule S. Suk Q.D. Chu 1994 Cisplatin as a radiation sensitizer in the treatment of advanced head and neck cancers. Results of a phase II study Cancer 74 1927 32 (Pubitemid 24301856)
7. E.E. Cohen M.W. Lingen E.E. Vokes 2004 The expanding role of systemic therapy in head and neck cancer J Clin Oncol 22 1743 52 (Pubitemid 41079815)
8. J.S. Cooper T.F. Pajak A.A. Forastiere 2004 Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck N Engl J Med 350 1937 44 (Pubitemid 38580196)
9. A. Eckardt D. Rades V. Rudat 2002 Prospective phase II study of neoadjuvant radiochemotherapy in advanced operable carcinoma of the mouth cavity. 3-year outcome Mund Kiefer Gesichtschir 6 117 21
10. A. Eckardt B. Sinikovic C. Hofele 2007 Preoperative paclitaxel/ carboplatin radiochemotherapy for stage III/IV resectable oral and oropharyngeal cancer: seven-year follow-up of a phase II trial Oncology 73 198 203
11. A. Eckardt G. Wegener J.H. Karstens 2006 Preoperative radiochemotherapy of advanced resectable cancer of the oral cavity with cisplatin vs paclitaxel/carboplatin. Analysis of two multimodality treatment concepts Mund Kiefer Gesichtschir 10 30 6
12. H.T. Eich M. Loschcke M. Scheer 2008 Neoadjuvant radiochemotherapy and radical resection for advanced squamous cell carcinoma of the oral cavity. Outcome of 134 patients Strahlenther Onkol 184 23 9
13. A. Ernst-Stecken G. Grabenbauer H. Iro 2004 Phase II trial of hyperfractionated accelerated split-course radiochemotherapy with 5-FU and Cis-DDP in advanced head and neck cancer: results and toxicity Strahlenther Onkol 180 805 10 (Pubitemid 40100830)
14. R. Fietkau H. Iro G.G. Grabenbauer 1991 Simultaneous radiotherapy and chemotherapy with cisplatin and 5-fluorouracil in advanced head and neck tumors Strahlenther Onkol 167 693 700
15. G. Fountzilas C. Tolis A. Kalogera-Fountzila 2005 Induction chemotherapy with cisplatin, epirubicin, and paclitaxel (CEP), followed by concomitant radiotherapy and weekly paclitaxel for the management of locally advanced nasopharyngeal carcinoma. A Hellenic Cooperative Oncology Group phase II study Strahlenther Onkol 181 223 30 (Pubitemid 40585541)
16. A.S. Garden J. Harris E.E. Vokes 2004 Preliminary results of Radiation Therapy Oncology Group 97-03: a randomized phase II trial of concurrent radiation and chemotherapy for advanced squamous cell carcinomas of the head and neck J Clin Oncol 22 2856 64 (Pubitemid 41079904)
17. A.S. Glicksman H.J. Wanebo G. Slotman 1997 Concurrent platinum-based chemotherapy and hyperfractionated radiotherapy with late intensification in advanced head and neck cancer Int J Radiat Oncol Biol Phys 39 721 9 (Pubitemid 27441442)
18. R.M. Hermann R. Krech J. Hartlapp 2001 The value of qualitative regression grading as a prognostic factor for survival after preoperative radiochemotherapy in patients with advanced head and neck cancer Strahlenther Onkol 177 277 82 (Pubitemid 32531703)
19. U. Hoeller I. Biertz S. Flinzberg 2006 Hyperfractionated-accelerated radiotherapy followed by radical surgery in locally advanced tumors of the oral cavity Strahlenther Onkol 182 157 63
20. P. Kessler G. Grabenbauer A. Leher 2007 Five year survival of patients with primary oral squamous cell carcinoma. Comparison of two treatment protocols in a prospective study Strahlenther Onkol 183 184 9 (Pubitemid 46570755)
21. T. Kirita K. Ohgi H. Shimooka 1999 Preoperative concurrent chemoradiotherapy plus radical surgery for advanced squamous cell carcinoma of the oral cavity: an analysis of long-term results Oral Oncol 35 597 606 (Pubitemid 29506987)
22. C. Klug D. Berzaczy M. Voracek 2008 Preoperative chemoradiotherapy in the management of oral cancer: a review J Craniomaxillofac Surg 36 75 88
23. C. Klug D. Keszthelyi O. Ploder 2004 Neoadjuvant radiochemotherapy of oral cavity and oropharyngeal cancer: evaluation of tumor response by CT differs from histopathologic response assessment in a significant fraction of patients Head Neck 26 224 31 (Pubitemid 38292732)
24. C. Klug A. Wutzl C. Kermer 2005 Preoperative radiochemotherapy and radical resection for stages II to IV oral and oropharyngeal cancer: grade of regression as crucial prognostic factor Int J Oral Maxillofac Surg 34 262 7 (Pubitemid 40309739)
25. O. Koelbl A. Rosenwald M. Haberl 2001 p53 and Ki-67 as predictive markers for radiosensitivity in squamous cell carcinoma of the oral cavity? An immunohistochemical and clinicopathologic study Int J Radiat Oncol Biol Phys 49 147 54 (Pubitemid 32041287)
26. A.F. Kovacs S. Mose H.D. Bottcher 2005 Multimodality treatment including postoperative radiation and concurrent chemotherapy with weekly docetaxel is feasible and effective in patients with oral and oropharyngeal cancer Strahlenther Onkol 181 26 34 (Pubitemid 40174983)
27. T. Kuhnt A. Becker S. Pigorsch 2003 Aggressive simultaneous radiochemotherapy with cisplatin and paclitaxel in combination with accelerated hyperfractionated radiotherapy in locally advanced head and neck tumors. Results of a phase I-II trial Strahlenther Onkol 179 673 81 (Pubitemid 37254661)
28. M. Kunkel G.J. Forster T.E. Reichert 2003 Radiation response non-invasively imaged by [18F]FDG-PET predicts local tumor control and survival in advanced oral squamous cell carcinoma Oral Oncol 39 170 7 (Pubitemid 36050923)
29. P. Lavertu D.J. Adelstein J.P. Saxton 1997 Management of the neck in a randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in resectable stage III and IV squamous cell head and neck cancer Head Neck 19 559 66 (Pubitemid 27407309)
30. P. Lavertu D.J. Adelstein J.P. Saxton 1999 Aggressive concurrent chemoradiotherapy for squamous cell head and neck cancer: an 8-year single-institution experience Arch Otolaryngol Head Neck Surg 125 142 8 (Pubitemid 29085261)
31. C. Mohr W. Bohndorf J. Carstens 1994 Preoperative radiochemotherapy and radical surgery in comparison with radical surgery alone. A prospective, multicentric, randomized DÖSAK study of advanced squamous cell carcinoma of the oral cavity and the oropharynx (a 3-year follow-up) Int J Oral Maxillofac Surg 23 140 8 (Pubitemid 124012646)
32. R. Mucke M. Blynow P.G. Ziegler 1999 Simultaneous radiochemotherapy with carboplatin in patients with inoperable advanced stage III and IV head and neck tumors Strahlenther Onkol 175 213 7 (Pubitemid 29237109)
33. K. Onizawa H. Yoshida K. Ohara 2006 Predictive factors for the histologic response to preoperative radiotherapy in advanced oral cancer J Oral Maxillofac Surg 64 81 6 (Pubitemid 41797768)
34. J.P. Pignon J. Bourhis C. Domenge 2000 Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer Lancet 355 949 55 (Pubitemid 30240530)
35. T. Reuther N.K. Posselt J. Rabbels 2006 Oral squamous cell carcinoma. Retrospective analysis of therapy results and prognosis by neoadjuvant, preoperative radiochemotherapy Mund Kiefer Gesichtschir 10 18 29
36. J. Schultze H. Schillmoller J.C. Roldan 2006 Preoperative radiochemotherapy for advanced oral cavity tumours: the Kiel DÖSAK experience regarding curability and quality of life Mund Kiefer Gesichtschir 10 249 57
37. C. Schutze A. Dorfler W. Eicheler 2007 Combination of EGFR/HER2 tyrosine kinase inhibition by BIBW 2992 and BIBW 2669 with irradiation in FaDu human squamous cell carcinoma Strahlenther Onkol 183 256 64 (Pubitemid 46725991)
38. G.J. Slotman C.H. Doolittle A.S. Glicksman 1992 Preoperative combined chemotherapy and radiation therapy plus radical surgery in advanced head and neck cancer. Five-year results with impressive complete response rates and high survival Cancer 69 2736 43
39. D. Soulieres N.N. Senzer E.E. Vokes 2004 Multicenter phase II study of erlotinib, an oral epidermal growth factor receptor tyrosine kinase inhibitor, in patients with recurrent or metastatic squamous cell cancer of the head and neck J Clin Oncol 22 77 85 (Pubitemid 41095117)
40. M. Suntharalingam M.L. Haas D.A. Van Echo 2001 Predictors of response and survival after concurrent chemotherapy and radiation for locally advanced squamous cell carcinomas of the head and neck Cancer 91 548 54 (Pubitemid 32105700)
41. H. Wanebo P. Chougule N. Ready 2001 Surgical resection is necessary to maximize tumor control in function-preserving, aggressive chemoradiation protocols for advanced squamous cancer of the head and neck (stage III and IV) Ann Surg Oncol 8 644 50 (Pubitemid 32847929)
42. T.G. Wendt G.G. Grabenbauer C.M. Rodel 1998 Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: a randomized multicenter study J Clin Oncol 16 1318 24 (Pubitemid 28175746)
43. N. Zamboglou H. Pape T. Schnabel 1989 Combined radiotherapy with cis- or carboplatin in advanced head and neck tumors Strahlenther Onkol 165 647 51 (Pubitemid 19232996)